SUNPHARMA— Sun Pharmaceutical

Sun Pharmaceuticals [SUNPHARMA] demonstrates consistent risk behavior over the past six months, with beta metrics suggesting relative stability compared to broader market movements.

The Indian equity market concluded the session with marginal gains as investors remained hesitant to build positions. While select defensive and telecom stocks rallied, energy and metal counters faced selling pressure.